Katherine R. McCurdy

Founder at The Barth Syndrome Foundation, Inc.

Commercial Services

Profile

Katherine R.
McCurdy is the founder of The Barth Syndrome Foundation, Inc. where she currently holds the titles of Chairman and Chairman-Scientific & Medical Advisory.
The company was founded in 2000.

Katherine R. McCurdy active positions

Companies	Position	Start
The Barth Syndrome Foundation, Inc. The Barth Syndrome Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Barth Syndrome Foundation, Inc. is a non-profit organization that focuses on Barth Syndrome, an ultra-rare genetic condition that primarily affects males. The private company is based in Larchmont, NY and was founded in 2000 by Katherine R. McCurdy. The condition is characterized by cardiac abnormalities, exercise intolerance, muscle weakness, severe fatigue, recurrent infections, and delayed growth. The foundation aims to raise awareness about the condition and fund research to find a cure. There are currently no FDA- or EMA-approved therapies for patients with Barth Syndrome.	Founder	1999-12-31

All active positions of Katherine R. McCurdy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Katherine R. McCurdy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
The Barth Syndrome Foundation, Inc. The Barth Syndrome Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Barth Syndrome Foundation, Inc. is a non-profit organization that focuses on Barth Syndrome, an ultra-rare genetic condition that primarily affects males. The private company is based in Larchmont, NY and was founded in 2000 by Katherine R. McCurdy. The condition is characterized by cardiac abnormalities, exercise intolerance, muscle weakness, severe fatigue, recurrent infections, and delayed growth. The foundation aims to raise awareness about the condition and fund research to find a cure. There are currently no FDA- or EMA-approved therapies for patients with Barth Syndrome.	Commercial Services